The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants <29 weeks gestation

Carmel Collins, Robert Gibson, Maria Makrides, Andrew McPhee, Thomas Sullivan, Peter Davis, Marta Tio, Karen Simmer, V Rajadurai, Scott Morris

    Research output: Contribution to journalArticlepeer-review

    16 Citations (Scopus)

    Fingerprint Dive into the research topics of 'The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants <29 weeks gestation'. Together they form a unique fingerprint.

    Medicine & Life Sciences